Can a patient sign electronically?

Yes. Electronic signatures are valid under the ESIGN Act (15 U.S.C. ch. 96) and most state UETA laws where not excluded; ensure intent, consent, attribution, and reliable record retention are documented.

Is a notary or witness required?

Not generally required for HIPAA authorizations, but some states or institutional policies may require notarization or witnesses for certain proxy signatures; check state and facility rules before finalizing.

How do you revoke an authorization?

Revocation should be a dated written notice signed by the patient or representative. Retain the revocation and update records to stop further disclosures as instructed.

What happens if the form is incomplete?

Incomplete fields, missing signatures, or unclear recipient info can invalidate the authorization, delay treatment or records release, and expose the provider to compliance risk.

Are special privacy notices required?

Yes. Consumer-facing records must meet ESIGN disclosure requirements for electronic records and HIPAA requires notice of privacy practices when PHI is shared.

How long should I keep executed forms?

Retain per federal and state rules: at least 6 years for HIPAA records (45 CFR §164.530(j)) and generally 3 years where tax issues apply (IRC §6501(a)); check state law for longer periods.

Electronic Signature
Templates
Healthcare
Citalopram Patient Authorization Form

Citalopram Patient Authorization Form

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

Citalopram Patient Authorization Form

Patient Information

Full legal name

Date of birth:

Gender: Female Male Other Decline to State

Home address

Primary phone:

Email (optional):

Emergency contact

Insurance Information

Primary insurance provider

Policy number:

Group number:

Subscriber name (as shown on insurance)

Medical History & Medication Information

Current medications (include prescription, over-the-counter, herbal supplements) Drug allergies and reactions Significant medical/psychiatric history

Has there been a history of seizure disorder, heart rhythm abnormality, or prolonged QT interval? Yes No

Current or recent (past 30 days) use of monoamine oxidase inhibitors (MAOIs) or other serotonergic agents? Yes No

Female patients: Are you pregnant, planning pregnancy, or breastfeeding? Yes No Unsure

Treatment Details

Prescribing provider

Intended indication:

Initial dose (mg):

Dose frequency:

Anticipated duration / refills:

Pharmacy preference

Risks, Benefits, and Alternatives

I acknowledge that my prescriber has explained the nature and purpose of citalopram treatment, including expected benefits, common side effects (such as nausea, sleep disturbance, headache, sexual dysfunction), and less common but serious risks including serotonin syndrome, hyponatremia, increased bleeding risk with concomitant anticoagulants or NSAIDs, QT interval prolongation, and the risk of worsening mood or suicidal thoughts particularly at treatment initiation or dose changes.

I understand alternatives to citalopram may include other antidepressant medications, psychotherapy, or no pharmacologic treatment, and these alternatives were discussed with me. I have had the opportunity to ask questions and they were answered to my satisfaction.

I acknowledge that abrupt discontinuation may cause withdrawal symptoms and that dose changes should be made under medical supervision.

I have been advised to avoid starting a monoamine oxidase inhibitor (MAOI) within a specified washout period before starting citalopram and to inform my provider of all prescription and nonprescription medications and supplements.

I will seek immediate medical attention if I experience symptoms of serotonin syndrome (e.g., high fever, muscle rigidity, rapid heart rate), severe allergic reaction, chest pain, fainting, or new or worsening suicidal thoughts.

A copy of medication counseling and any medication guide has been offered and/or provided to me.

Patient acknowledgment

I acknowledge that I have been informed of the risks and benefits of citalopram and understand the information provided above.

Authorization to Prescribe, Dispense, and Disclose

By signing this form I authorize the prescribing clinician and clinic staff to prescribe citalopram on my behalf and to communicate with pharmacies, insurers, and other health care providers as necessary for the purposes of treatment, medication management, prior authorization, and care coordination.

I specifically authorize the release and disclosure of my protected health information related to this medication, including diagnosis, prescription details, relevant laboratory and clinical notes, to pharmacies, health plans, and other treating clinicians for purposes of dispensing, payment, utilization review, and continuity of care.

Entities authorized to receive information (check all that apply)

Pharmacy Insurance/Pharmacy Benefit Manager Other treating providers

Other persons/entities to disclose to (Specify)

I understand that once my protected health information is disclosed pursuant to this authorization it may be subject to re-disclosure by the recipient and may no longer be protected by applicable privacy regulations.

Duration and Revocation

This authorization is valid until the earlier of: the date specified below, or one year from the date of signature, unless revoked in writing. To revoke this authorization I must submit a written request to the prescribing clinic; revocation will not affect actions taken in reliance on this authorization prior to receipt of the revocation.

Expiration date (if different from one year):

Patient Rights and Certification

I understand that I have the right to refuse to sign this authorization and that my treatment, payment, enrollment, or eligibility for benefits will not be conditioned on signing this form, except to the extent that the authorization is necessary to obtain insurance payment for this medication or to permit certain disclosures required to provide the medication. I understand that I may request a copy of this signed authorization.

I certify that the information I have provided on this form is true and accurate to the best of my knowledge. I consent to the use of citalopram as described in this form and authorize the prescribing clinician to proceed with prescribing and coordinating pharmacy and insurer communications related to this medication.

Patient signature required

Patient Name:

Signature:

Date:

If signed by guardian or legally authorized representative — Relationship:

What the Citalopram Patient Authorization Form Is

The Citalopram Patient Authorization Form documents a patient's informed consent for prescription, administration, or release of information related to citalopram therapy. It records patient identifiers, treatment specifics, disclosure permissions, and signature evidence that the patient understands risks and agrees to treatment or data sharing. Providers use this form to satisfy clinical, administrative, and privacy requirements while creating a reproducible record. The form typically includes effective dates, scope limits, recipient designations for records, and revocation instructions so the authorization can be enforced and audited.

Why a Clear Authorization Form Matters

A complete, compliant authorization protects patient rights, documents informed consent, and reduces clinical and legal exposure by making scope and recipients explicit.

Who Completes and Relies on This Form

Proper completion promotes continuity of care and helps demonstrate compliance with privacy and prescribing rules during audits or care transitions.

Prescribing clinicians and psychiatrists responsible for documenting informed consent and treatment plans for antidepressant therapy.
Medical records and release-of-information teams that process patient data requests and fulfill disclosure instructions.
Pharmacy staff and specialty pharmacy programs handling medication dispensing and prior-authorizations tied to the consent.

Stepwise Walkthrough to Complete the Form

Complete the form in a consistent sequence to reduce errors and ensure every required field and authentication step is captured.

01

Verify Identity: Confirm patient ID using government photo ID before completing the form.
02

Complete Core Fields: Enter name, DOB, medication, purpose, and recipient details precisely.
03

Add Authentication: Collect signature, date, and witness or notary information if required by policy or state law.
04

Distribute Copies: Provide signed copies to patient and retain one in the medical record system.

Typical Processing Flow for an Authorization

The usual routing moves the completed form from clinician to medical record, with optional third-party sharing per the patient's directions.

Clinician Completion: Clinician or authorized staff fills and signs the authorization.
Record Entry: Upload to the patient chart and tag for release-of-information workflows.
Third-Party Release: Transmit records to authorized recipients per the form's scope.
Retention: Store the executed form according to the facility retention policy.

Configuring an Electronic Workflow for This Form

When digitizing, set up authentication, field validation, and storage rules so e-submissions meet legal and clinical standards.

Field	Configuration
Authentication Method	Email link, SMS code, or stronger MFA as required
Required Fields	Mark name, DOB, signature, and date as mandatory
Audit Trail	Capture timestamps, IP, and user actions automatically
Retention Policy	Automate storage to clinical record archive per policy

Platform and Integration Considerations

Integrations reduce manual upload and preserve metadata; ensure the vendor supports HIPAA BAAs and secure transport.

EHR Integrations: Salesforce, Epic, or custom API connections
Cloud Storage: Box, Google Drive, or enterprise file stores
Directory Services: SSO support via Microsoft 365 or Azure

Essential Elements of a Professional Authorization Form

A well-drafted authorization balances clinical detail with clear privacy language and administrative fields so providers and patients understand rights and limits.

Patient Identifiers

Full legal name, DOB, and medical record number are essential to avoid mismatches and ensure correct patient linkage in records.

Medication Details

Explicitly name citalopram, dose, route, and frequency so pharmacies and clinicians know the treatment terms and avoid dispensing errors.

Scope of Release

Define exactly what records may be shared and time limits for disclosure to prevent overbroad or indefinite authorizations.

Expiration and Revocation

Include an effective date, expiration date, and clear revocation instructions and method for withdrawing consent.

Privacy Disclosures

State HIPAA-related privacy information and whether redisclosure by recipients is permitted or prohibited.

Signature and Authority

Collect patient or authorized representative signature, printed name, date, and relationship to establish legal authority to sign.

Security and Compliance Snapshot

Encryption in transit: TLS 1.2/1.3

Encryption at rest: AES-256

HIPAA compliance: BAA required for PHI handling

Audit trail: Timestamps, IP, and action log

Authentication options: Email, SMS, KBA, or MFA

Regulatory standards: ESIGN, UETA, 21 CFR support

Consequences of Incorrect or Incomplete Authorization

Invalid Consent: Patient data released incorrectly

HIPAA Fines: Civil penalties and corrective action

Clinical Delay: Treatment may be postponed

Insurance Denial: Claims rejected for lacking authorization

Legal Liability: Civil suits for privacy breaches

Record Inconsistency: Mismatched records across systems

Common Preparation Pitfalls to Avoid

Omitting a patient identifier such as DOB or MRN, which leads to record mismatching and delays in pharmacy processing.
Using ambiguous scope language like 'all records' without time limits, which can invalidate or over-broaden permission.
Failing to collect a dated signature or using initials where a signature is required, risking noncompliance with payer or provider rules.
Neglecting to document revocation procedures or failing to provide a signed copy to the patient, generating disputes later.

Selecting an eSignature Vendor — Pricing and Feature Snapshot

Compare starting price and essential features for common eSignature vendors. signNow is shown first per platform comparison conventions.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day trial	Varies	Varies	Varies	Varies
Bulk Send	Yes	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No
Envelope Cap	No cap	100 envelopes/user/year	Varies	Varies	Varies

Common Questions About Using the Citalopram Patient Authorization Form

Answers to frequent questions about validity, electronic signatures, witnesses, and revocation for patient authorization forms.

Need help? Contact support

Can a patient sign electronically?
Yes. Electronic signatures are valid under the ESIGN Act (15 U.S.C. ch. 96) and most state UETA laws where not excluded; ensure intent, consent, attribution, and reliable record retention are documented.
Is a notary or witness required?
Not generally required for HIPAA authorizations, but some states or institutional policies may require notarization or witnesses for certain proxy signatures; check state and facility rules before finalizing.
How do you revoke an authorization?
Revocation should be a dated written notice signed by the patient or representative. Retain the revocation and update records to stop further disclosures as instructed.
What happens if the form is incomplete?
Incomplete fields, missing signatures, or unclear recipient info can invalidate the authorization, delay treatment or records release, and expose the provider to compliance risk.
Are special privacy notices required?
Yes. Consumer-facing records must meet ESIGN disclosure requirements for electronic records and HIPAA requires notice of privacy practices when PHI is shared.
How long should I keep executed forms?
Retain per federal and state rules: at least 6 years for HIPAA records (45 CFR §164.530(j)) and generally 3 years where tax issues apply (IRC §6501(a)); check state law for longer periods.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now